Skip to main content
OpenTrials
Completed

NCT Number: NCT05840146

Kineesiotaping for Patients With LCPD

Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Legg-Calve-Perthes Disease Bone Diseases Femur Head Necrosis Musculoskeletal Diseases Osteonecrosis

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University-Cerrahpasa

Istanbul, Turkey (Türkiye)

About this study

Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having received unilateral LCPD diagnosis,
  • Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
  • Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance

Exclusion criteria

  • Having a history of any other hip pathologies,
  • Having allergy to polyacrylate adhesive,
  • Having used analgesic medication within the previous three days.

Treatment and study plan

Kinesiotaping

Other

Two I-strips were used:

  • The first-third of one I-strip began at the posterior iliac crest, without tension as an anchor. Then the patient actively flexed and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension.
  • The first-third of the second I-strip was applied starting at the anterior iliac crest, without tension as an anchor. The patient actively extended and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension.

Sham Taping

Other

A single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the hip.

Primary outcomes

  1. Immediate Clinical Efficacy on Activity Related Hip

    Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)

    Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)

Secondary outcomes

  1. Immediate Clinical Efficacy on Hip Abduction ROM

    Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)

    goniometric range of motion (ROM)

  2. Immediate Clinical Efficacy on Functional Task Durations

    Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)

    10-meters walk task duration (sec) and 10-step climbing task duration (sec)

  3. Immediate Clinical Efficacy on Balance test durations

    Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)

    One leg stance test duration (sec) and Tandem walk test duration (sec)

  4. Immediate Clinical Efficacy on Gluteus medius muscle strength

    Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)

    muscle strength by handheld dynamometer (Ibs)

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Official study title

Effects of Kinesiotaping in Patients With Legg-Calvé-Perthes Disease: A Randomized, Double-blind, Placebo-controlled Trial

Important dates

Study start
2017
Primary completion
2020
Study completion
2021
First posted
May 3, 2023
Registry last updated
May 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.